J. Powell

发表

D. Perrier, D. Jung, J. Powell, 1980, Clinical pharmacology and therapeutics.

Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables

P. Watkins, J. Powell, Rachel Tyson, 2020, Frontiers in Pharmacology.

Precision drug dosing: A major opportunity for patients and pharmacists

J. Powell, J. H. Patterson, Yanguang Cao, 2018, Journal of the American College of Clinical Pharmacy.

Why Has Model‐Informed Precision Dosing Not Yet Become Common Clinical Reality? Lessons From the Past and a Roadmap for the Future

Y. Daali, L. Lesko, L. Aarons, 2017, Clinical pharmacology and therapeutics.

Albuterol Extended‐Release Products: A Comparison of Steady‐State Pharmacokinetics

J. Powell, E. Hussey, K. Donn, 1991, Pharmacotherapy.

Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.

J. Powell, 2016, The New England journal of medicine.

Influence of rifampin on tocainide pharmacokinetics in humans.

J. Powell, J. H. Patterson, T. Rice, 1989, Clinical pharmacy.

Digoxin-quinidine interaction.

D. Perrier, P. Fenster, J. Powell, 1979, Annals of internal medicine.

Pharmacokinetics of Ondansetron in Patients with Hepatic Insufficiency

J. Powell, G. Dukes, D. Hermann, 1996, Journal of clinical pharmacology.

Inhibition of Tolbutamide Elimination by Cimetidine but not Ranitidine

J. Powell, J. Rogers, Emily W. Cate, 1986, Journal of clinical pharmacology.

The influence of cigarette smoking and sex on theophylline disposition.

L. Sansom, J. Powell, S. Vožeh, 2015, The American review of respiratory disease.

Digoxin-quinidine interaction.

P. Fenster, J. Powell, W. Hager, 1979, Annals of internal medicine.

Clinical pharmacology of carvedilol in normal volunteers

L. Cubeddu, J. Powell, F. Varin, 1987, Clinical pharmacology and therapeutics.

Response to “Personalized Dosing = Approved Wide Dose Ranges + Dose Titration”

J. Powell, D. Weiner, Yaning Wang, 2020, Clinical pharmacology and therapeutics.

Dosing Recommendations for New Oral Anticoagulants--Reply.

J. Powell, 2015, JAMA.

Are new oral anticoagulant dosing recommendations optimal for all patients?

J. Powell, 2015, JAMA.

Cimetidine decreases theophylline clearance.

J. Powell, R. Dorr, J. Bentley, 1981, The American review of respiratory disease.

Effect of Metoclopramide, Bethanechol, and Loperamide on Gastric Residence Time, Gastric Emptying, and Mouth‐to‐Cecum Transit Time

W. Heizer, J. Powell, G. Dukes, 1989, Pharmacotherapy.

Effect of Altering Small Bowel Transit Time on Sustained Release Theophylline Absorption

W. Heizer, J. Powell, G. Dukes, 1989, Journal of clinical pharmacology.

The Effects of Antacid and Propantheline on the Absorption of Oral Ranitidine

L. Fabre, J. Powell, K. Donn, 1984, Pharmacotherapy.

The direct enantiomeric determination of (-)- and (+)-propranolol in human serum by high-performance liquid chromatography on a chiral stationary phase.

J. Powell, I. Wainer, K. Donn, 1984, Journal of chromatography.

Ranitidine Does Not Alter Single-Dose Carbamazepin Pharmacokinetics in Healthy Adults

J. Powell, J. Messenheimer, L. Mallet, 1985, Drug intelligence & clinical pharmacy.

Effect of duration of lidocaine infusion and route of cimetidine administration on lidocaine pharmacokinetics.

J. Powell, J. H. Patterson, W. Wargin, 1986, Clinical pharmacy.

Ranitidine at very large doses does not inhibit theophylline elimination

J. Powell, J. Donohue, H. Kelly, 1986, Clinical pharmacology and therapeutics.

A Single‐dose pharmacokinetic study of the antisickling agent cetiedil

J. Powell, E. Orringer, R. Cross, 1986, Clinical pharmacology and therapeutics.

The Pharmacokinetic Basis for H2‐antagonist Drug Interactions: Concepts and Implications

J. Powell, K. Donn, 1983, Journal of clinical gastroenterology.

Comparison of Verapamil, Diltiazem, and Labetalol on the Bioavailability and Metabolism of Imipramine

Thomas F. Krol, J. Powell, D. Hermann, 1992, Journal of clinical pharmacology.

Drug Dosing Recommendations for All Patients: A Roadmap for Change

J. Powell, D. Weiner, Yaning Wang, 2020, Clinical pharmacology and therapeutics.

Absolute Bioavailability of Phenytoin After 3‐Phosphoryloxymethyl Phenytoin Disodium (ACC‐9653)Administration to Humans

B. Jamerson, K. Brouwer, J. Powell, 1990, Epilepsia.

Determination of albuterol concentrations in human plasma using solid-phase extraction and high-performance liquid chromatography with fluorescence detection.

J. Powell, R. Bland, R. Tanner, 1990, Journal of pharmaceutical and biomedical analysis.

The effect of oral cimetidine on total and unbound serum lidocaine concentrations in patients with suspected myocardial infarction.

J. Powell, J. McCue, J. Bauman, 1987, International journal of cardiology.

Phenobarbital Pharmacokinetics and Bioavailability in Adults

D. Perrier, J. Powell, K. Conrad, 1982, Journal of clinical pharmacology.

Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens

I. M. Davis, T. L. Lloyd, J. Powell, 1991, Antimicrobial Agents and Chemotherapy.

Bioavailability of cefuroxime axetil formulations.

J. Powell, K. Donn, N. C. James, 1994, Journal of pharmaceutical sciences.

Leveraging a Previously Published Population Pharmacokinetic Model to Predict Rivaroxaban Exposure in Real‐World Patients

J. Powell, J. H. Patterson, D. Weiner, 2022, Journal of clinical pharmacology.

Rivaroxaban Precision Dosing Strategy for Real‐World Atrial Fibrillation Patients

P. Watkins, J. Powell, D. Weiner, 2020, Clinical and translational science.

Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact

T. Wiltshire, K. Brouwer, J. Powell, 2017, Clinical and translational science.

Leveraging Prior Quantitative Knowledge to Guide Drug Development Decisions and Regulatory Science Recommendations: Impact of FDA Pharmacometrics During 2004–2006

Yaning Wang, Lawrence J Lesko, Rajanikanth Madabushi, 2008, Journal of clinical pharmacology.

Bioavailability of ACC‐9653 (Phenytoin Prodrug)

J. E. Evans, B. Jamerson, J. Powell, 1989, Epilepsia.

Evaluation of the absorption from some commercial sustained-release theophylline products

L. Sansom, J. Powell, S. Riegelman, 1980, Journal of Pharmacokinetics and Biopharmaceutics.

Evaluation of the absorption from some commercial enteric-release theophylline products

L. Sansom, J. Powell, S. Riegelman, 2005, Journal of Pharmacokinetics and Biopharmaceutics.

The Influence of H2‐Receptor Antagonists on Steady‐State Concentrations of Propranolol and 4‐Hydroxypropranolol

J. Powell, J. Rogers, K. Donn, 1984, Journal of clinical pharmacology.

Cimetidine and Carbamazepine: A Complex Drug Interaction

J. Powell, J. Clark, Michael J. Dalton, 1986, Epilepsia.

The Influence of Cimetidine on Single‐Dose Carbamazepine Pharmacokinetics

J. Powell, J. Messenheimer, Michael J. Dalton, 1985, Epilepsia.

The Effect of Cimetidine Dose Timing on Oral Propranolol Kinetics in Adults

J. Powell, M. Asgharnejad, Marion Danis, 1988, Journal of clinical pharmacology.

Lack of Effect of Histamine H2‐Receptor Antagonists on Indocyanine Green Disposition Measured by Two Methods

J. Powell, J. Rogers, K. Donn, 1984, Journal of clinical pharmacology.

Effect of the Addition of Ciprofloxacin on Theophylline Pharmacokinetics in Subjects Inhibited by Cimetidine

J. Powell, R. Quenzer, H. Kelly, 1992, The Annals of pharmacotherapy.

Sumatriptan Absorption from Different Regions of the Human Gastrointestinal Tract

I. M. Davis, W. Heizer, J. Powell, 2004, Pharmaceutical Research.

Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia.

L B Sheiner, J R Powell, L. Sheiner, 1978, The American review of respiratory disease.

Digitoxin-quinidine interaction: pharmacokinetic evaluation.

P. Fenster, J. Powell, F. Marcus, 1980, Annals of internal medicine.

Changes in theophylline clearance during acute illness.

L. Sheiner, P. Hopewell, J. Powell, 1978, JAMA.

Venous Irritation Related to Intravenous Administration of Phenytoin versus Fosphenytoin

B. Jamerson, K. Brouwer, J. Powell, 1994, Pharmacotherapy.

Developing the Pharmacist's Role in Monitoring Total Parenteral Nutrition

J. Powell, G. Cupit, 1974 .

Pharmacokinetics ofCefuroxime Axetil andCefaclor: Relationship ofConcentrations inSerumtoMICsfor CommonRespiratory Pathogens

I. M. Davis, T. L. Lloyd, J. Powell, 1991 .

Releasing the Human Spirit in Developing Drugs

J. Powell, E. Randinitis, R. Lalonde, 2012, International Journal of Pharmaceutical Medicine.

Mechanism of the Vasodilatory Effect of Carvedilol in Normal Volunteers: A Comparison with Labetalol

L. Cubeddu, J. Powell, F. Varin, 1987, Journal of cardiovascular pharmacology.

Age and gender effects on ondansetron pharmacokinetics: Evaluation of healthy aged volunteers

J. Powell, J. Pritchard, J. Bryson, 1992, Clinical pharmacology and therapeutics.

Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria

V. Shah, L. Sansom, J. Powell, 1980, Journal of Pharmacokinetics and Biopharmaceutics.

A proposal for scientific framework enabling specific population drug dosing recommendations

N. Stockbridge, P. Zhao, J. Powell, 2015, Journal of clinical pharmacology.

The Strategic Plan of the American College of Clinical Pharmacy 1998–2000

J. Powell, D. Covey, K. Lake, 1998, Pharmacotherapy.

Histamine H2-antagonist drug interactions in perspective: mechanistic concepts and clinical implications.

J. Powell, K. Donn, 1984, The American journal of medicine.

Intraindividual variability in theophylline pharmacokinetics: Statistical verification in 39 of 60 healthy young adults

L. Sansom, J. Powell, S. Riegelman, 1982, Journal of Pharmacokinetics and Biopharmaceutics.

Effect of quinine on digoxin kinetics

P. Fenster, J. Powell, S. Goldman, 1980, Clinical pharmacology and therapeutics.

Albuterol Extended‐Release Products: Effect of Food on the Pharmacokinetics of Single Oral Doses of Volmax® and Proventil® Repetabs® in Healthy Male Volunteers

J. Powell, E. Hussey, Gary E. Pakes, 1991, Journal of clinical pharmacology.

Effect of Sodium Acid Pyrophosphate on Ranitidine Bioavailability and Gastrointestinal Transit Time

A. Parr, J. Powell, K. Koch, 1993, Pharmaceutical Research.

Influence of a Continuous Cimetidine Infusion on Lidocaine Plasma Concentrations in Patients

J. Powell, J. H. Patterson, W. Wargin, 1985 .

Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications

Yaning Wang, Jogarao V. S. Gobburu, P. Marroum, 2005, The AAPS Journal.

Research by Academic Clinical Pharmacists

J. Powell, 1982, Drug intelligence & clinical pharmacy.

Proceedings of a Symposium: The Clinical Pharmacist in Drug Research and Development

J. Powell, D. Helling, 1987 .

ETHANOL PHARMACODYNAMICS AT LOW BLOOD CONCENTRATIONS

J. Powell, E. Ellinwood, K. Muir, 1996, American journal of therapeutics.

Effect of ranitidine hydrochloride (150 mg twice daily) on the pharmacokinetics of increasing doses of ethanol (0.15, 0.3, 0.6 g kg-1).

L. Lacey, J. Powell, S. Gupta, 1996, British journal of clinical pharmacology.

Liquid chromatographic assay and disposition of carvedilol in healthy volunteers.

L. Cubeddu, J. Powell, F. Varin, 1986, Journal of pharmaceutical sciences.

Dabigatran Dosing Proposal for Adults With Atrial Fibrillation: Stress‐Testing Renal Function Range in Real World Patients

J. Powell, D. Weiner, D. Gonzalez, 2023, Clinical pharmacology and therapeutics.

Regarding Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012–2018

J. Powell, D. Weiner, J. Cook, 2020, Clinical pharmacology and therapeutics.

Comparison of Quantitative Methods to Assess Hepatic Function: Pugh's Classification, Indocyanine Green, Antipyrine, and Dextromethorphan

J. Powell, G. Dukes, D. Hermann, 1995, Pharmacotherapy.

Digoxin‐Quinidine Interaction in Patients with Chronic Renal Failure

D. Perrier, P. Fenster, J. Powell, 1982, Circulation.